These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Treatment of anemia in renal transplantation: impact of a stricter application of hemoglobin targets. Gentil MA, Pérez-Valdivia MA, González-Roncero FM, López-Mendoza M, Cabello V, Bernal G, Suñer M, Pereira P. Transplant Proc; 2008 Nov; 40(9):2916-8. PubMed ID: 19010146 [Abstract] [Full Text] [Related]
24. Hemoglobin variability does not predict mortality in peritoneal dialysis patients. Chen HC, Chen KH, Lin YJ, Chang CJ, Tian YC, Yang CW, Hung CC. Chang Gung Med J; 2012 Nov; 35(1):79-87. PubMed ID: 22483431 [Abstract] [Full Text] [Related]
25. Influence of hemoglobin level on in-hospital prognosis in patients with acute coronary syndrome. González-Ferrer JJ, García-Rubira JC, Balcones DV, Gil IN, Barrio RC, Fuentes-Ferrer M, Fernández-Ortiz A, Macaya C. Rev Esp Cardiol; 2008 Sep; 61(9):945-52. PubMed ID: 18775236 [Abstract] [Full Text] [Related]
27. [Is the management of anemia in hemodialysis patients improving in France? Results of the DiaNE study]. Kessler M, Landais P, Canivet E, Yver L, Bataille P, Brillet G, Commenges B, Koné S. Nephrol Ther; 2009 Apr; 5(2):114-21. PubMed ID: 19042175 [Abstract] [Full Text] [Related]
29. Past, present, and future of chronic kidney disease anemia management in the United States. Wish JB. Adv Chronic Kidney Dis; 2009 Mar; 16(2):101-8. PubMed ID: 19233069 [Abstract] [Full Text] [Related]
30. Study of anemia in long-term care (SALT): prevalence of anemia and its relationship with the risk of falls in nursing home residents. Pandya N, Bookhart B, Mody SH, Funk Orsini PA, Reardon G. Curr Med Res Opin; 2008 Aug; 24(8):2139-49. PubMed ID: 18561876 [Abstract] [Full Text] [Related]
31. Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL. Bradbury BD, Do TP, Winkelmayer WC, Critchlow CW, Brookhart MA. Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):932-40. PubMed ID: 19572312 [Abstract] [Full Text] [Related]
32. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly. Sulowicz W, Locatelli F, Ryckelynck JP, Balla J, Csiky B, Harris K, Ehrhard P, Beyer U, PROTOS Study Investigators. Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476 [Abstract] [Full Text] [Related]
34. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study. Yokoyama H, Kawaguchi T, Wada T, Takahashi Y, Higashi T, Yamazaki S, Fukuhara S, Akiba T, Akizawa T, Asano Y, Kurokawa K, Saito A, J-DOPPS Research Group. Nephron Clin Pract; 2008 Jul; 109(2):c100-8. PubMed ID: 18596379 [Abstract] [Full Text] [Related]
35. [Incidence and management of anemia in renal transplantation: an observational-French study]. Choukroun G, Deray G, Glotz D, Lebranchu Y, Dussol B, Bourbigot B, Lefrançois N, Cassuto-Viguier E, Toupance O, Hacen C, Lang P, Mazouz H, Martinez F. Nephrol Ther; 2008 Dec; 4(7):575-83. PubMed ID: 18672417 [Abstract] [Full Text] [Related]